71034 - Diagnosis and Treatment of Primary and Secondary Arterial Hypertension

Learning outcomes

To make the learner able to: 1) effectively reckognize the various determinants of the cardiovascular risk profile, discriminating  primary or secondary forms, 2) evaluate the subject's risk profile in an integrated manner and apply the quantification algorithms of the same and the principles of the guidelines, 3) identify the most appropriate therapeutic strategy on the basis of the global risk profile and 4) acquire a deep theoretical / practical knowledge of the modalities of dietary-behavioral and pharmacological intervention towards the main factors of modifiable risk with particular interest for arterial hypertension and dyslipidemias.

Course contents

Integrated therapeutic management of arterial hypertension and hypercholesterolemia in the context of type 2 diabetes and heart failure.

Principles of rationalization of polypharmacy in patients at high cardiovascular risk with multiple risk factors.

Readings/Bibliography

Cicero AFG, Fogacci F, Kuwabara M, Borghi C. Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update. Medicina (Kaunas). 2021 Jan 10;57(1):58. doi: 10.3390/medicina57010058.

Cicero AFG, Landolfo M, Ventura F, Borghi C. Current pharmacotherapeutic options for primary dyslipidemia in adults. Expert Opin Pharmacother. 2019 Jul;20(10):1277-1288. doi: 10.1080/14656566.2019.1604687.

Cicero AFG, Bove M, Borghi C. Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):9-15. doi: 10.1080/17425255.2018.1416094.

Teaching methods

Standard lectures

Assessment methods

Attendance of at least 75% of the course

Office hours

See the website of Arrigo Francesco Giuseppe Cicero